Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
About Two River Group
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products. Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
Arie Belldegrun, M.D., FACS
Chairman and Partner

Dr Belldegrun joined Two River Group Holdings as Chairman and partner in May 2008 .Dr. Belldegrun is Professor and Chief of Urologic Oncology, and holds the Carol and Roy Doumani Chair in Urologic Oncology, at the David Geffen School of Medicine at the University of California, Los Angeles. He received his medical degree at the Hebrew University Hadassah Medical School, and conducted his post-doctoral studies at the Weizmann Institute of Science in Israel. He completed his Urologic Surgery residency at Harvard Medical School in 1985 and his Surgical Oncology fellowship at the National Cancer Institute/National Institute of Health (NIH) in 1988. He is certified by the American Board of Urology and is a Fellow of the American College of Surgeons and the American Association of Genitourinary Surgeons (AAGUS).

Dr. Belldegrun is also an accomplished entrepreneur. He is the founder and founding chairman of Agensys Inc., a privately held biotechnology company developing fully human antibody cancer therapeutics based on novel and clinically relevant targets. In December 2007 Agensys was acquired by Astellas Pharma, Inc. in a deal valued at $537 million. He is also the Vice-Chairman of the Board of Directors and Chairman of the Scientific Advisory Board of Cougar Biotechnology, a publicly traded biotechnology company with a specific focus on the field of oncology. Cougar Biotechnology is currently in phase 3 clinical trial in prostate cancer with a targeted oral small molecule called Abiraterone Acetate.

Dr. Belldegrun is on the scientific boards of several biotechnology and pharmaceutical companies and is a reviewer for many medical journals and granting organizations. He served as Chairman of the Molecular and Biological Technology Committee of the American Urological Association and member of its Technology Assessment Council, as a member of the Governor's council on Bioscience for the State of California, and as a biotechnology group leader and member of The Los Angeles Economy and Jobs Committee established in October 2006 by Mayor Antonio Villaraigosa. He is the author of several books on prostate and kidney cancers, holds several biopharmaceutical patents, and has written over 400 scientific publications with an emphasis on Urologic Oncology, cancer vaccines , and targeted cancer therapy.

Dr. Belldegrun resides in Los Angeles with his wife Dr. Rebecka Belldegrun, President and CEO of Bellco Capital, and their four children.


Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.		 Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.
© 2008 Two River Group Holdings, LLC | Terms of Use | Privacy Policy
Two River Group Holdings is a New York based venture capital firm that is focus on the formation of new companies that will acquire the rights to commerically develop pharmaceuticals, medical, therapeutics, diagnostic, and other healthcare related products.